Applications of 4-Methoxyphenylacetamide in Industrial Manufacturing

4-Methoxyphenylacetamide serves as a precise and reliable intermediate in several advanced manufacturing sectors. As a direct manufacturer, we supply this raw material to multiple downstream industries which demand exacting standards in synthesis, process integration, and finished product performance.

1. Pharmaceutical Intermediates for Antipyretic and Analgesic APIs

Leading pharmaceutical companies use 4-Methoxyphenylacetamide as a key precursor in the synthesis of selective analgesic and antipyretic active pharmaceutical ingredients. Its high purity ensures consistent reaction yields necessary in regulated environments. The compound participates in amide coupling and etherification steps under stringent GMP conditions, supporting batch-to-batch reproducibility crucial for API manufacturing.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• US Pharmacopeia (USP) and European Pharmacopoeia (Ph. Eur.) monograph requirements for intermediates
• FDA 21 CFR Part 211 (Finished Pharmaceuticals)
• ISO 9001:2015 Quality Management Systems

Typical usage ratio

• Ranges from 0.6 to 1.2 molar equivalents per API synthesis batch; variations reflect API target yield and reaction route optimization

Downstream process integration

• Introduced at the initial condensation step for amide formation
• Serves as electrophilic partner in O-methylation and amidation protocols
• Integrated into multi-step reactors for subsequent hydrolysis and further derivatization
• Subject to inline QC and batch traceability systems for regulated environments

Final product types

• Paracetamol derivatives
• Acetaminophen analogues
• Other non-opioid analgesic APIs
• Bulk pharmaceutical intermediates for contract manufacturing

2. Agrochemical Synthesis for Selective Herbicide Production

Major agrochemical formulators utilize 4-Methoxyphenylacetamide as a building block in the manufacture of selective herbicide actives. Its controlled reactivity supports chlorination, nitration, or acylation to form target substituted phenylacetic herbicides. This enables scalable formulation of active compounds compliant with international agricultural safety codes.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• FAO/WHO Codex Alimentarius standards for pesticide residues
• Regulation (EC) No 1107/2009 on plant protection products
• ISO 9001 and ISO 14001 for Environmental and Quality Management

Typical usage ratio

• Applied at 0.4–0.8 molar equivalents per target herbicide molecule; tuning based on desired selectivity and throughput

Downstream process integration

• Dosed at the primary aromatic substitution or etherification stage
• Feeds into flow reactors for continuous synthesis lines
• Requires solvent compatibility checks for scalable agrochemical blending
• Monitored for residuals via in-process HPLC or GC analysis

Final product types

• Selectively substituted phenylacetic acid herbicides
• Plant growth regulators
• Pre-emergence weed control active ingredients
• Bulk actives for downstream formulation concentrates

3. Fine Chemical Synthesis for Fragrance Intermediates

Manufacturers in the flavor and fragrance sector apply 4-Methoxyphenylacetamide for crafting high-value aromatic compounds. It contributes methoxy functionality and aromatic character to intermediates used in formulation of musks and specialty esters. Strict trace impurity control supports downstream olfactory consistency vital for perfumery.

Industry compliance standards

• IFRA (International Fragrance Association) Standards for chemical purity and allergen control
• REACH Regulation (EC) No 1907/2006 for registration and safety
• ISO 9001:2015 for production traceability
• US Food and Drug Administration (FDA) CFR 21 Part 172.515 (Flavorings)

Typical usage ratio

• Dosage varies from 2–10% weight/weight relative to the final intermediate blend; adjusted for end-note impact and process loss

Downstream process integration

• Included in batch reactors during esterification or methylation steps
• Undergoes solid–liquid separation before purification
• Sourced in high-purity, low-odor grades for fragrance synthesis
• Cleanroom handling ensures absence of cross-contamination for specialty perfumery

Final product types

• Fragrance intermediates for fine perfumes
• Musk odorant precursors
• Specialty aroma esters
• Floral-scented functional additives

4. Specialty Dye and Pigment Synthesis

Advanced dye manufacturers rely on 4-Methoxyphenylacetamide as a controlled aromatic precursor in the synthesis of specialty dyes and pigments. Its functional group enables introduction into diazotization and coupling reactions, providing core chromophores for colorants with enhanced solubility and fastness required in textile and paper applications.

Industry compliance standards

• OEKO-TEX Standard 100 for restricted substances in textiles
• EU Regulation (EC) No 1907/2006 (REACH) for dye intermediates
• ISO 9001:2015 for pigment traceability
• EN 71-3:2019 Safety of Toys – migration of colorants

Typical usage ratio

• Used at 0.2–0.6 molar equivalents per chromophore backbone; specifics depend on pigment type and desired shade intensity

Downstream process integration

• Charged into batch reactors during the aromatic amination stage
• Subjected to diazotization followed by azocoupling
• Blended into pigment dispersion systems after purification
• Receipt in micro-crystalline powder form ensures rapid dissolution in base solvents

Final product types

• Disperse dyes for textile printing
• Synthetic pigments for inkjet inks
• Azo-based colorants for plastics and coatings
• Reactive dye precursors for specialty papers

5. Research Chemicals for Medicinal Chemistry and Custom Synthesis

CROs and medicinal chemistry labs acquire 4-Methoxyphenylacetamide as a functionalized aromatic scaffold for structure–activity relationship studies and compound library expansion. Its profile facilitates amide bond formation and ether-linked modifications, allowing pharmacophore exploration in novel candidate development. We provide COA and batch records to meet custom synthesis project requirements.

Industry compliance standards

• OECD Good Laboratory Practice (GLP) for non-clinical studies
• ISO 17025 for analytical laboratory competence
• Material traceability per ICH Q7 GMP if supplied for preclinical investigations
• Chemical safety data supported by GHS-compliant SDS

Typical usage ratio

• Applied in 0.05–1.0 molar equivalents per synthetic protocol; scale depends on route exploration and batch size

Downstream process integration

• Supplied as milligram to multi-kilogram batches for parallel synthesis
• Utilized in exploratory condensation, acylation, or alkylation steps
• Enables rapid analog synthesis in combinatorial chemistry platforms
• QC-confirmed for purity, identity, and elemental composition prior to library inclusion

Final product types

• Lead compound analogues
• Structure–activity relationship (SAR) libraries
• Molecular probes for pharmacological studies
• Custom intermediates for biotech screening